微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
NeuroMetrix (NASDAQ:NURO) +65%
Reneo Pharmaceuticals (NASDAQ:RPHM) +25%
Neoleukin Therapeutics (NASDAQ:NLTX) +23%
InspireMD (NASDAQ:NSPR) +16%
Chembio Diagnostics (N...查看全文
$InspireMD(NSPR)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001493152-21-002127 Act: 34 Size: 4 MB 网页链接
$InspireMD(NSPR)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-21-002128 Act: 33 Size: 9 MB 网页链接
$InspireMD(NSPR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-21-005153 Act: 34 Size: 58 KB 网页链接
$InspireMD(NSPR)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001493152-21-001258 Act: 33 Size: 3 MB 网页链接
$InspireMD(NSPR)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-21-001240 Act: 34 Size: 9 MB 网页链接
$InspireMD(NSPR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001493152-21-000702 Act: 34 Size: 36 KB 网页链接
$InspireMD(NSPR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001493152-21-000694 Act: 33 Size: 17 KB 网页链接
$InspireMD(NSPR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001535610-21-000068 Act: 34 Size: 13 KB 网页链接
$InspireMD(NSPR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-20-020767 Act: 34 Size: 232 KB 网页链接
$InspireMD(NSPR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-20-020759 Act: 34 Size: 2 MB 网页链接